Provided by Tiger Fintech (Singapore) Pte. Ltd.

Atara Biotherapeutics

7.15
+0.13001.85%
Volume:56.82K
Turnover:391.01K
Market Cap:41.89M
PE:-0.63
High:7.21
Open:7.05
Low:6.58
Close:7.02
Loading ...

Atara Biotherapeutics reports clinical hold placed on Ebvallo programs, ATA3219

TIPRANKS
·
21 Jan

US FDA puts clinical hold on Atara's trials for cancer cell therapies

Reuters
·
21 Jan

Atara Biotherapeutics Inc: FDA Has Placed a Clinical Hold on Atara's Active Investigational New Drug (Ind) Applications

THOMSON REUTERS
·
21 Jan

Atara Biotherapeutics Inc: Screening and Enrollment of New Participants in Both Programs Have Been Paused

THOMSON REUTERS
·
21 Jan

Atara Biotherapeutics Provides Update on Clinical Programs Related to Ebvallo™ (Tabelecleucel) and ATA3219

THOMSON REUTERS
·
21 Jan

Atara Biotherapeutics Provides Update on Clinical Programs Related to EBVALLO™ (tabelecleucel) and ATA3219

Business Wire
·
21 Jan

ATRA Stock Down After FDA Issues CRL for Rare Blood Cancer Candidate

Zacks
·
17 Jan

Atara Biotherapeutics price target lowered to $17 from $21 at Canaccord

TIPRANKS
·
17 Jan

Atara Biotherapeutics Inc : Canaccord Genuity Cuts Target Price to $17 From $21

THOMSON REUTERS
·
17 Jan

Sector Update: Health Care Stocks Rise Thursday Afternoon

MT Newswires Live
·
17 Jan

Top Midday Decliners

MT Newswires Live
·
17 Jan

Atara Biotherapeutics Shares Plunge 38% Following FDA Response to EBVALLO Application

GuruFocus.com
·
17 Jan

Atara Biotherapeutics Shares Tumble Amid 'Compliance Issues' Involving Manufacturing Plant for Ebvallo

MT Newswires Live
·
17 Jan

US Stocks Edge Lower; Retail Sales Increase Less Than Expected

Benzinga
·
16 Jan

Atara Biotherapeutics Shares Down 43.8% After US FDA Declines to Approve Co's Cancer Therapy

THOMSON REUTERS
·
16 Jan

FDA Rejects Atara's Request to Bring Blood Cancer Treatment to Market

Dow Jones
·
16 Jan